Fig. 3 | Scientific Reports

Fig. 3

From: Eurycomalactone switched hepatocellular carcinoma cells into quiescence through 5’tRFAla/DVL/β-catenin pathway inhibition

Fig. 3

ELT suppressed the β-catenin pathway in PLC/PRF/5 and HUH7 cells. (A, B) Western blotting results of β-catenin-related proteins in PLC/PRF/5 and HUH7 cells. (C, D) Quantification of the protein content of total, nuclear, and cytoplasmic β-catenin, Cyclin D1, c-myc, and Survivin in the two cell lines. Tubulin served as an internal control. Results were shown as the mean ± SD from three distinct experimental trials. *p < 0.05. The samples derived from the same experiment, and the blots were processed in parallel. Original blots were presented in Supplementary Fig S5.

Back to article page